Demonstration of drug-dependent antibodies in two patients with neutrophenia and successful treatment with granulocyte-colony-stimulating factor

Transfusion

Volumn 39, Issue 5, 1999, Pages 527-530

  Meyer, O ^b   Gaedicke, G ^b   Salama, Abdulgabar ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD16 ANTIGEN; CEFOTAXIME; CLINDAMYCIN; CLONIDINE; COMPLEMENT COMPONENT C3B RECEPTOR; DIHYDRALAZINE; DIPYRONE; DRUG ANTIBODY; ERYTHROMYCIN; FENTANYL; GRANULOCYTE ANTIBODY; GRANULOCYTE COLONY STIMULATING FACTOR; INSULIN; MIDAZOLAM; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; PIPERACILLIN; TEICOPLANIN; THIOPENTAL; TOBRAMYCIN;

ACUTE DISEASE; ADOLESCENT; AGGLUTINATION TEST; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CASE REPORT; DIABETIC COMA; DRUG EFFICACY; DRUG WITHDRAWAL; EPIDURAL ABSCESS; FEMALE; FEVER; GRANULOCYTE; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOTHERAPY; INFECTION RISK; LEUKOCYTE COUNT; LEUKOPOIESIS; MALE; NEUTROPENIA; NEUTROPHIL; PROTEIN IMMOBILIZATION; SCHOOL CHILD;

ADOLESCENT; ANTIBODY FORMATION; CHILD; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; NEUTROPENIA; TREATMENT OUTCOME;

EID: 0032959290     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39050527.x     Document Type: Article

References (13)

1. Pisciotta AV, Ebbe S, Lennon EJ, et al. Agranulocytosis following administration of phenothiazine derivates. Am J Med 1958;25:210-23.
2. Pretty HM, Gosselin G, Colpron G, Long LA. Agranulocytosis: a report of 30 cases. Can Med Assoc J 1965;93:1058-64.
3. Heit W, Heimpel H, Fischer A, Frickhofen N. Drug-induced agranulocytosis: evidence for the commitment of bone marrow haematopoiesis. Scand J Haematol 1985;35:459-68.
4. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study. JAMA 1986;256:1749-57.
5. Dale DC. Neutropenia. In: Beutler E, Lichtmann MA, Coller BS, Kipps TJ, eds. Williams hematology. New York: McGraw-Hill, 1995:815-24.
6. Salama A, Schütz B, Kiefel V, et al. Immune-mediated agranulocytosis related to drugs and their metabolites: mode of sensitization and heterogeneity of antibodies. Br J Haematol 1989;127:32.
7. Nand S, Bayer R, Prinz RA, et al. Granulocyte-macrophage colony stimulating factor for the treatment of drug induced agranulocytosis. Am J Hematol 1991;37:267-9.
8. Patton WN, Holyoake TL, Yates JM, et al. Accelerated recovery from drug-induced agranulocytosis following G-CSF therapy. Br J Haematol 1992;80:564-5.
9. Bradford CR, Ong EL, Hendrick DJ, Saunders PW. Use of colony stimulating factors for the treatment of drug-induced agranulocytosis (letter). Br J Haematol 1993;84:182-3.
10. Cappellari G, Gaio A, Cavallaro A, et al. Use of colony stimulating factors for the treatment of drug-induced agranulocytosis (letter). Br J Haematol 1993;84:183-4.
11. Rouveix B, Lassoued K, Vittecoq D, Regnier B. Neutropenia due to beta lactamine antibodies. Br Med J Clin Res Ed 1983;287:1832-4.
12. Bux J, Kober B, Kiefel V, Mueller-Eckhardt C. Analysis of granulocyte-reactive antibodies using an immunoassay based upon monoclonal-antibody-speciflc immobilization of granulocyte antigens. Transfus Med 1993;3:157-62.
13. Bux J, Behrens G, Jaeger G, Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 1998;91:181-6.